Walleye Capital LLC Compugen LTD Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $84,823 - $142,601	-30,733 Closed	0 $0
Q4 2021 Mar 03, 2022	SELL	$4.09 - $7.16 $940 - $1,646	-230 Reduced 0.74%	30,733 $132,000
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $120,582 - $166,735	20,790 Added 204.36%	30,963 $185,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $1.08 Million - $1.44 Million	-157,667 Reduced 93.94%	10,173 $84,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $1.29 Million - $2.31 Million	167,840 New	167,840 $1.44 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $138M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.